Summary of Study ST002565

This data is available at the NIH Common Fund's National Metabolomics Data Repository (NMDR) website, the Metabolomics Workbench, https://www.metabolomicsworkbench.org, where it has been assigned Project ID PR001653. The data can be accessed directly via it's Project DOI: 10.21228/M81Q6Q This work is supported by NIH grant, U2C- DK119886.

See: https://www.metabolomicsworkbench.org/about/howtocite.php

This study contains a large results data set and is not available in the mwTab file. It is only available for download via FTP as data file(s) here.

Perform statistical analysis  |  Show all samples  |  Show named metabolites  |  Download named metabolite data  
Download mwTab file (text)   |  Download mwTab file(JSON)   |  Download data files (Contains raw data)
Study IDST002565
Study TitleMetabolomic profiling of PMM2-CDG after siRNA mediated KD of AKR1b1 - 13C6 glucose and fructose study
Study SummaryAbnormal polyol metabolism has been predominantly associated with diabetes, where excess glucose is converted to sorbitol by aldose reductase (AR). Recently, abnormal polyol metabolism has also been implicated in phosphomannomutase 2-congenital disorder of glycosylation (PMM2-CDG), and epalrestat, an AR inhibitor, proposed as a potential therapy for this disorder. Given that the PMM enzyme is not closely connected to polyol metabolism, and, unlike in diabetes, PMM2-CDG does not present with hyperglycemia in blood, the increased polyol production, and the therapeutic mechanism of epalrestat in PMM2-CDG remained largely elusive. PMM2-CDG is caused by deficiency of the PMM enzyme and results in a depletion of mannose-1-P and guanosine diphosphate mannose (GDP-mannose), which is essential for glycosylation. Here, we show that apart from glycosylation abnormalities, PMM2 deficiency also leads to changes in intracellular glucose flux, which results in an increase in intracellular polyols. Ssing tracer glucose studies, we demonstrate that AR inhibition diverts glucose flux away from polyol production towards the synthesis of sugar nucleotides.
Institute
Mayo Clinic
Last NameRadenkovic
First NameSilvia
Address200 2nd Ave SW Rochester MN, USA
Emailradenkovic.silvia@mayo.edu
Phone507(77) 6-6107
Submit Date2023-04-18
Raw Data AvailableYes
Raw Data File Type(s)mzML
Analysis Type DetailLC-MS
Release Date2023-07-18
Release Version1
Silvia Radenkovic Silvia Radenkovic
https://dx.doi.org/10.21228/M81Q6Q
ftp://www.metabolomicsworkbench.org/Studies/ application/zip

Select appropriate tab below to view additional metadata details:


Factors:

Subject type: Cultured cells; Subject species: Homo sapiens (Factor headings shown in green)

mb_sample_id local_sample_id Genotype Treatment
SA257927SR08PMM2-CDG 12C fructose + 12C glucose
SA257928SR04PMM2-CDG 12C fructose + 12C glucose
SA257929SR03PMM2-CDG 12C fructose + 12C glucose
SA257930SR07PMM2-CDG 12C fructose + 12C glucose
SA257931SR05PMM2-CDG 12C fructose+13C fructose
SA257932SR06PMM2-CDG 12C fructose+13C fructose
SA257933SR02PMM2-CDG 13C glu + 12C fructose
SA257934SR01PMM2-CDG 13C glu + 12C fructose
SA257935SR10PMM2-CDG 5.5mM 13C glucose
SA257936SR09PMM2-CDG 5.5mM 13C glucose
SA257937SR11PMM2-CDG 5.5mM glucose +
SA257938SR12PMM2-CDG 5.5mM glucose +
SA257939SR19WT 12C fructose + 12C glucose
SA257940SR16WT 12C fructose + 12C glucose
SA257941SR15WT 12C fructose + 12C glucose
SA257942SR20WT 12C fructose + 12C glucose
SA257943SR18WT 12C fructose+13C fructose
SA257944SR17WT 12C fructose+13C fructose
SA257945SR13WT 13C glu + 12C fructose
SA257946SR14WT 13C glu + 12C fructose
SA257947SR24WT 5.5mM 13C glucose
SA257948SR23WT 5.5mM 13C glucose
SA257949SR22WT 5.5mM glucose +
SA257950SR21WT 5.5mM glucose +
Showing results 1 to 24 of 24
  logo